MicroRNA Market: By Type (MicroRNA Arrays, Next Gen Sequencing, Immunoassay, PCR-Based Assay), By Application (Research and Development, Clinical Diagnostics), By End-user (Research and Academic Institutes, Biopharmaceutical Companies, Diagnostic Centers ) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

MicroRNA market size was valued at USD 440 million in 2023 and is poised to grow at a CAGR of 26.1% from 2024 to 2030. The inception of microRNA (miRNA) diagnostics in clinics has hastened the developments in precision medicine in cancer treatment. In addition, microRNAs are ideal postulants for noninvasive biomarkers in tumors due to many cells secreting miRNA identified in various body fluids. MicroRNA, with its roles in gene regulation and disease pathways, creates a substantial market demand, which in turn drives the growth of the market. A combination of factors, such as gene regulation, noninvasive biomarkers in cancer treatment, epigenetic modification, and biogenesis machinery, is driving the global miRNA market.

Additionally, the rise in Research Use efforts focused on addressing unmet medical needs in tumors is strengthening market growth. Collaborations between academic institutions, market players, and regulatory authorities aid knowledge sharing and accelerate miRNA market development. While comparing cells or tissues from young and old individuals, contrastingly expressed miRNA tends to be inarticulate in the latter; this suggests that the molecular pathway that regulates miRNA biogenesis is altered during aging and gene expression.

 

Microrna Market Summary

Study Period

2024 - 2030

Base Year

2023

CAGR

26.1%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Microrna Market Dynamics

The rise in the prevalence of tumors/cancers worldwide is the primary market driver in the global microRNA market during the forecast period. Cancer affects the immune cells that carry immunity throughout the body. In November 2023, researchers at the American College of Surgeons, Chicago, stated that microRNA can be utilized in biomarkers to improve the long-term outcomes for patients with breast cancer. Moreover, R&D, technology innovation, disease association, and regulatory landscapes increase market acceptance. 

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018-2022) and forecast (2023-2030)
  • The report covers the in-detail insights about the competitor’s overview, company share analysis, key market developments and their key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report track recent innovations, key developments and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory frame work and reimbursement scenario.

Microrna Market Segmentation

By Type
  • MicroRNA Arrays,
  • Next Gen Sequencing,
  • Immunoassay,
  • PCR-Based Assay
By Application
  • Research and Development,
  • Clinical Diagnostics
By End User
  • Research and Academic Institutes,
  • Biopharmaceutical Companies,
  • Diagnostic Centers

Frequently Asked Questions

The MicroRNA market size is expanded to be valued at USD 440 million.

The MicroRNA market is poised to grow at a significant CAGR of 26.1% from 2023 to 2030

Merck Kgaa, QIAGEN, Thermo Fisher Scientific Inc., Synlogic, Genecopoeia, Inc., Horizon Discovery Ltd., New England Bio labs, Quanta bio, Nanostring, Biogenex, Seqmatic LLC, Miltenyi Biotech, Agilent Technologies, Inc., Promega Corporation, Abcam Plc, KANEKA CORPORATION

1.Executive Summary
2.Global Microrna Market Introduction 
2.1.Global Microrna Market  - Taxonomy
2.2.Global Microrna Market  - Definitions
2.2.1.Type 
2.2.2.Application
2.2.3.End User
2.2.4.Region
3.Global Microrna Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Microrna Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Microrna Market  By Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. MicroRNA Arrays,
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Next Gen Sequencing,
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Immunoassay,
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. PCR-Based Assay
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global Microrna Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Research and Development,
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Clinical Diagnostics
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7.Global Microrna Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Research and Academic Institutes,
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Biopharmaceutical Companies,
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Diagnostic Centers
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Microrna Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Microrna Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.MicroRNA Arrays,
9.1.2.Next Gen Sequencing,
9.1.3.Immunoassay,
9.1.4.PCR-Based Assay
9.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Research and Development,
9.2.2.Clinical Diagnostics
9.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Research and Academic Institutes,
9.3.2.Biopharmaceutical Companies,
9.3.3.Diagnostic Centers
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Microrna Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.MicroRNA Arrays,
10.1.2.Next Gen Sequencing,
10.1.3.Immunoassay,
10.1.4.PCR-Based Assay
10.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Research and Development,
10.2.2.Clinical Diagnostics
10.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Research and Academic Institutes,
10.3.2.Biopharmaceutical Companies,
10.3.3.Diagnostic Centers
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Microrna Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.MicroRNA Arrays,
11.1.2.Next Gen Sequencing,
11.1.3.Immunoassay,
11.1.4.PCR-Based Assay
11.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Research and Development,
11.2.2.Clinical Diagnostics
11.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Research and Academic Institutes,
11.3.2.Biopharmaceutical Companies,
11.3.3.Diagnostic Centers
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Microrna Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.MicroRNA Arrays,
12.1.2.Next Gen Sequencing,
12.1.3.Immunoassay,
12.1.4.PCR-Based Assay
12.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Research and Development,
12.2.2.Clinical Diagnostics
12.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Research and Academic Institutes,
12.3.2.Biopharmaceutical Companies,
12.3.3.Diagnostic Centers
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Microrna Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.MicroRNA Arrays,
13.1.2.Next Gen Sequencing,
13.1.3.Immunoassay,
13.1.4.PCR-Based Assay
13.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Research and Development,
13.2.2.Clinical Diagnostics
13.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Research and Academic Institutes,
13.3.2.Biopharmaceutical Companies,
13.3.3.Diagnostic Centers
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Merck KGaA
14.2.2.QIAGEN
14.2.3.Thermo Fisher Scientific Inc.
14.2.4.Synlogic
14.2.5.GeneCopoeia, Inc.
14.2.6.Horizon Discovery Ltd.
14.2.7.New England Bio labs
14.2.8.Quanta bio
14.2.9.Nano String
14.2.10.BioGenex
14.2.11.SeqMatic LLC
14.2.12.Miltenyi Biotech
14.2.13.Agilent Technologies, Inc.,
14.2.14.Promega Corporation
14.2.15.Abcam plc
14.2.16.Kaneka Corporation 
15. Research Methodology 
16. Appendix and Abbreviations 
  • Merck KGaA
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • Synlogic
  • GeneCopoeia, Inc.
  • Horizon Discovery Ltd.
  • New England Bio labs
  • Quanta bio
  • Nano String
  • BioGenex
  • SeqMatic LLC
  • Miltenyi Biotech
  • Agilent Technologies, Inc.,
  • Promega Corporation
  • Abcam plc
  • Kaneka Corporation 

Adjacent Markets